Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Markku Mali"'
Autor:
Kalle H. Sipilä, Vipin Ranga, Pekka Rappu, Markku Mali, Laura Pirilä, Ilona Heino, Johanna Jokinen, Jarmo Käpylä, Mark S. Johnson, Jyrki Heino
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Abstract We report the extent, specific sites and structural requirements of joint inflammation related citrullination in extracellular proteins. A total of 40 synovial fluid samples derived from chronically inflamed human joints were analysed by hep
Externí odkaz:
https://doaj.org/article/1499297be840416aa311dd65cde115bb
Autor:
Laura Pirilä, Juhani Knuuti, Mikko Koivumäki, Petteri Lankinen, Vesa Oikonen, Xiang-Guo Li, Sirpa Jalkanen, Kristiina Santalahti, Riikka Viitanen, Tuula Tolvanen, Ia Kohonen, Anne Roivainen, Pirjo Nuutila, Helena E. Virtanen, Antti Saraste, Markku Mali, Sami Suilamo, Anu Autio, Olli Moisio, Ilpo Koskivirta, Kirsi Taimen
Publikováno v:
Journal of Nuclear Medicine. 62:577-583
Sialic acid-binding immunoglubulin-like lectin 9 (Siglec-9) is a ligand of vascular adhesion protein 1 (VAP-1). A gallium 68-labeled peptide of Siglec-9, 68Ga-DOTA-Siglec-9, holds promise as a novel PET tracer for imaging of inflammation. This first-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ccd5aa8ab9f55ea12cf625403880b19
https://doi.org/10.2967/jnumed.120.250696
https://doi.org/10.2967/jnumed.120.250696
Autor:
Riikka, Viitanen, Olli, Moisio, Petteri, Lankinen, Xiang-Guo, Li, Mikko, Koivumäki, Sami, Suilamo, Tuula, Tolvanen, Kirsi, Taimen, Markku, Mali, Ia, Kohonen, Ilpo, Koskivirta, Vesa, Oikonen, Helena, Virtanen, Kristiina, Santalahti, Anu, Autio, Antti, Saraste, Laura, Pirilä, Pirjo, Nuutila, Juhani, Knuuti, Sirpa, Jalkanen, Anne, Roivainen
Publikováno v:
Journal of Nuclear Medicine
Visual Abstract
Sialic acid–binding immunoglubulinlike lectin 9 (Siglec-9) is a ligand of vascular adhesion protein 1. A 68Ga-labeled peptide of Siglec-9, 68Ga-DOTA-Siglec-9, holds promise as a novel PET tracer for imaging of inflammation. Thi
Sialic acid–binding immunoglubulinlike lectin 9 (Siglec-9) is a ligand of vascular adhesion protein 1. A 68Ga-labeled peptide of Siglec-9, 68Ga-DOTA-Siglec-9, holds promise as a novel PET tracer for imaging of inflammation. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0df1e850fa18a8ee8388a9d39836ad0
https://pubmed.ncbi.nlm.nih.gov/32817143
https://pubmed.ncbi.nlm.nih.gov/32817143
Autor:
Markku Kauppi, Markku Mali, J Asikainen, L Kuusalo, M Puurtinen-Vilkki, P. Isomäki, Kirsi Taimen, J Paltta, Laura Pirilä, Kari Laiho, T Rannio, T. Yli-Kerttula, Hannu Kautiainen, Tuulikki Sokka, T. Uotila, Pekka Hannonen, S. Nyrhinen, Kalle Aaltonen, S. Kortelainen, P Ekman, Heidi Mäkinen
Publikováno v:
Scandinavian Journal of Rheumatology. 46:425-431
To assess what proportion of patients with disease-modifying anti-rheumatic drug (DMARD)-naïve early rheumatoid arthritis (ERA) reach 28-joint Disease Activity Score (DAS28) remission over 1 year, and remission variability across clinics in Finland.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9deb535232344ae66086d53ee36f4f3
https://doi.org/10.1080/03009742.2016.1266029
https://doi.org/10.1080/03009742.2016.1266029
Autor:
J. Paltta, Marjatta Strandberg, Seppo Laitinen, Markku Mali, Laura Pirilä, Ingrid E. Lundberg, Katriina Bamberg, Laura Mehtälä, Pauliina Nordling, Kim Pettersson, Niko Strandberg, Tanja Savukoski, Olli Arola, Fabricio Espinosa-Ortega
Publikováno v:
Poster Presentations.
Background The current biomarkers for the diagnosis and monitoring of diseased and injured skeletal muscles, such as creatine kinase (CK), have limited tissue specificity and incapability to differentiate between pathological and physiological change
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::878fd4732cf1084ea3b8cb9e66431fa9
https://doi.org/10.1136/annrheumdis-2019-eular.7436
https://doi.org/10.1136/annrheumdis-2019-eular.7436
Autor:
Marjatta Strandberg, Ingrid E. Lundberg, Seppo Laitinen, Kim Pettersson, Laura Mehtälä, Pauliina Nordling, Katriina Bamberg, Markku Mali, Laura Pirilä, Niko Strandberg, Tanja Savukoski, Olli Arola, Fabricio Espinosa-Ortega, J. Paltta
Publikováno v:
The journal of applied laboratory medicine. 5(2)
Background The current biomarkers for diagnosis and monitoring of injured and diseased skeletal muscles, such as creatine kinase (CK), have limited tissue specificity and incapability to differentiate between pathological and physiological changes. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e70e5a58650c328529fbe4457c853a0
https://pubmed.ncbi.nlm.nih.gov/32445386
https://pubmed.ncbi.nlm.nih.gov/32445386
Autor:
Pirjo Nuutila, Kirsi Taimen, Laura Pirilä, Antti Palomäki, Ulla Hohenthal, Sami Kajander, Anne Roivainen, Marko Seppänen, Soile Pauliina Salomäki, Jukka Kemppainen, Markku Mali
Publikováno v:
Contrast Media & Molecular Imaging, Vol 2019 (2019)
Contrast Media & Molecular Imaging
Contrast Media & Molecular Imaging
18F-Fluorodeoxyglucose positron-emission tomography (18F-FDG-PET) with computed tomography (CT) is effective for diagnosing large vessel vasculitis, but its usefulness in accurately diagnosing suspected, unselected vasculitis remains unknown. We eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::615cf1aa8e8c67eec70cee219d62ca65
Autor:
Yuya Takakubo, Riitta Komulainen, Heikki Relas, Riitta Koivuniemi, Yrjö T. Konttinen, Liisa Virkki, Heikki Valleala, Maija-Liisa Krogerus, Susanna Sihvonen, Urpo Yli-Kerttula, Dan Nordström, Eero Jukka, Jorma Vuotila, Satu Nyrhinen, Markku Mali
Publikováno v:
Clinical Rheumatology. 30:1447-1454
The aim of this study was to assess, based on observational data from the Finnish Register of Biological Treatment, the outcomes of switching an initial tumor necrosis factor (TNF) blocker to another in the treatment of rheumatoid arthritis (RA). RA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf50c0e7cd5d604c6b494a7c770d2641
https://doi.org/10.1007/s10067-011-1779-1
https://doi.org/10.1007/s10067-011-1779-1
Autor:
Kirsi Taimen, T. Uotila, Laura Pirilä, Pekka Hannonen, P Ekman, Heidi Mäkinen, S. Kortelainen, Tuulikki Sokka, P. Isomäki, Markku J Kauppi, J. Paltta, T. Rannio, T. Yli-Kerttula, K. Laiho, S. Nyrhinen, J. Asikainen, Kalle Aaltonen, L. Kuusalo, Maija Puurtinen-Vilkki, Hannu Kautiainen, Markku Mali
Publikováno v:
Annals of the Rheumatic Diseases. 75:697.3-698
Background Finnish national combination treatment trials [1,2] have demonstrated excellent outcomes in patients with early rheumatoid arthritis (RA) including 90% of patients reaching 28-joint Disease Activity Score (DAS28) remission. Whether similar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2251b728d6ca4ffe057da4b4c0a67572
https://doi.org/10.1136/annrheumdis-2016-eular.4894
https://doi.org/10.1136/annrheumdis-2016-eular.4894
Publikováno v:
Journal of Biological Chemistry. 268:24215-24222
The expression of syndecan-1, the prototype member of the cell surface proteoglycan family, follows morphogenetic rather than histological boundaries during organ formation. As a heparan sulfate-containing cell surface molecule, syndecan-1 can simult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ced892939c37bfcdb28d4f32d2a0e8a
https://doi.org/10.1016/s0021-9258(20)80513-4
https://doi.org/10.1016/s0021-9258(20)80513-4